thalidomide has been researched along with warfarin in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (17.07) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (34.15) | 29.6817 |
| 2010's | 19 (46.34) | 24.3611 |
| 2020's | 1 (2.44) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Majewski, F | 1 |
| Golbus, MS; Goldberg, JD | 1 |
| Fraumeni, JF | 1 |
| Hauser, GA; Mambourg, A | 1 |
| Beckman, DA; Brent, RL | 1 |
| Cohlan, SQ | 1 |
| Neubert, D | 1 |
| Owens, PK; Svensson, LA | 1 |
| Holmes, LB | 1 |
| Godeau, B; Lutz-Zarrouk, V; Michel, M; Pagnoux, C; Schaeffer, A | 1 |
| Jarmalaviciene, R; Kornysova, O; Maruska, A | 1 |
| Barbui, T; Comotti, B; Crippa, C; Elice, F; Galli, M; Rodeghiero, F | 1 |
| Brown, K; Chanan-Khan, A; Hahn, T; McCarthy, PL; Paplham, P; Roy, H; Scarpace, SL; van Besien, K | 1 |
| Mehta, P | 1 |
| Rajkumar, VS | 1 |
| Baumann, MA; Ikhlaque, N; Kathula, S; Seshadri, V | 1 |
| Chanan-Khan, A; Depaolo, D; Dimicelli, L; Doran, V; Landrigan, B; Marshal, P; Miller, KC; Padmanabhan, S; Yu, J | 1 |
| Hashimoto, Y; Hirano, T; Ito, Y; Mori, A; Uchino, M; Yonemura, K | 1 |
| Anderson, KC; Attal, M; Barlogie, B; Belch, A; Bladé, J; Boccadoro, M; Bringhen, S; Cavo, M; Dimopoulos, MA; Durie, BG; Harousseau, J; Hussein, MA; Joshua, D; Knop, S; Kyle, R; Lonial, S; Ludwig, H; Morgan, GJ; Niesvizky, R; Orlowski, RZ; Palumbo, A; Rajkumar, SV; Richardson, PG; San Miguel, J; Sezer, O; Shimizu, K; Sonneveld, P; Vesole, D; von Lilienfeld-Toal, M; Waage, A; Weber, D; Westin, J; Zangari, M; Zonder, JA | 1 |
| Catalano, L; Cavo, M; Cini, M; Gozzetti, A; Legnani, C; Masini, L; Palareti, G; Patriarca, F; Tacchetti, P; Tosi, P; Valdré, L; Zamagni, E | 1 |
| Irie, T; Mori, A; Morioka, M; Saito, M; Tanaka, M | 1 |
| Gajra, A; Singh, A | 1 |
| Baldini, L; Benevolo, G; Boccadoro, M; Bringhen, S; Callea, V; Caravita, T; Carella, AM; Cavo, M; Cellini, C; Crippa, C; Elice, F; Evangelista, A; Galli, M; Gentilini, F; Magarotto, V; Marasca, R; Montefusco, V; Morabito, F; Nozzoli, C; Offidani, M; Palumbo, A; Patriarca, F; Pescosta, N; Polloni, C; Pulini, S; Ria, R; Romano, A; Rossi, D; Tacchetti, P; Tosi, P; Zamagni, E; Zambello, R | 1 |
| Brioli, A; Cavo, M; Pantani, L; Tacchetti, P; Zamagni, E; Zannetti, B | 1 |
| Kristinsson, SY; Landgren, O | 1 |
| Hagiwara, K; Hosokawa, A; Takahashi, K; Uezato, H; Yamaguchi, S; Yamamoto, Y | 1 |
| Alexander, M; Kirsa, S; Mellor, JD | 1 |
| Alexander, M; Kirsa, S; Lingaratnam, S; Mellor, JD; Teoh, KC | 1 |
| Bennett, CL; Moore, TJ | 1 |
| Hattori, K; Ichikawa, A; Igarashi, A; Kato, A; Koshino, M; Nagata, K; Takano, H | 1 |
| Abdullah, D; Abdullah, WZ; Hussin, A; Roshan, TM; Zain, WS | 1 |
| Chen, N; Knight, R; Palmisano, M; Weiss, D; Zhou, S | 1 |
| Leebeek, FW | 1 |
| Cagnoli, GA; Cassina, M; Clementi, M; Di Gianantonio, E; Zuccarello, D | 1 |
| Ai, H; Chen, L; Liu, XJ; Mi, RH; Wei, XD; Yin, JJ; Yin, QS | 1 |
| Shimizu, M; Yamazaki, H | 1 |
12 review(s) available for thalidomide and warfarin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[On certain embryopathies induced by teratogenic agents (author's transl].
Topics: Abnormalities, Drug-Induced; Aminopterin; Busulfan; Chlorambucil; Cyclophosphamide; Ethanol; Germany, West; Heroin Dependence; Humans; Infant Mortality; Infant, Newborn; Lysergic Acid Diethylamide; Mercaptopurine; Nicotine; Phenytoin; Radiation Injuries; Teratogens; Thalidomide; Trimethadione; Warfarin | 1977 |
Mechanisms of teratogenesis.
Topics: Aminopterin; Androgens; Animals; Antithyroid Agents; Chromosome Aberrations; Coumarins; Diethylstilbestrol; Embryo, Mammalian; Ethanol; Female; Fetus; Humans; Methotrexate; Methylmercury Compounds; Mutagens; Nucleic Acids; Oxazoles; Phenytoin; Polychlorinated Biphenyls; Pregnancy; Progestins; Teratogens; Tetracycline; Thalidomide; Thyroid Hormones | 1984 |
Drugs and pregnancy.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Alcoholic Beverages; Animals; Anticonvulsants; Antineoplastic Agents; Diethylstilbestrol; Estrogens; Female; Fetal Death; Fetus; Humans; Hydantoins; Iodides; Organomercury Compounds; Pregnancy; Smoking; Teratogens; Tetracycline; Thalidomide; Thiourea; Warfarin | 1980 |
Teratogen-induced limb defects.
Topics: Chorionic Villi Sampling; Female; Humans; Limb Deformities, Congenital; Male; Misoprostol; Phenytoin; Pregnancy; Pregnancy in Diabetics; Substance-Related Disorders; Teratogens; Thalidomide; Valproic Acid; Warfarin | 2002 |
Thalidomide and thrombosis.
Topics: Angiogenesis Inhibitors; Drug Screening Assays, Antitumor; Heparin; Humans; Multiple Myeloma; Thalidomide; Thrombosis; Warfarin | 2003 |
[Brief report: stroke in multiple myeloma patient treated with thalidomide].
Topics: Aged; Anticoagulants; Aspirin; Embolism, Paradoxical; Foramen Ovale, Patent; Humans; Male; Multiple Myeloma; Neuroprotective Agents; Risk; Stockings, Compression; Stroke; Thalidomide; Venous Thrombosis; Warfarin | 2007 |
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
Topics: Antineoplastic Agents; Aspirin; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Lenalidomide; Multiple Myeloma; Premedication; Risk Assessment; Risk Factors; Thalidomide; Thrombosis; Venous Thromboembolism; Warfarin | 2008 |
Thromboembolism with immunomodulatory agents in the treatment of multiple myeloma.
Topics: Anticoagulants; Antineoplastic Agents; Aspirin; Heparin, Low-Molecular-Weight; Humans; Immunologic Factors; Lenalidomide; Multiple Myeloma; Thalidomide; Thromboembolism; Warfarin | 2011 |
Thalidomide thromboprophylaxis in multiple myeloma: a review of current evidence.
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Multiple Myeloma; Thalidomide; Venous Thromboembolism; Warfarin | 2012 |
Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR).
Topics: Adverse Drug Reaction Reporting Systems; Clopidogrel; Hemorrhage; Humans; Thalidomide; Thrombosis; Ticlopidine; United States; United States Food and Drug Administration; Warfarin | 2012 |
Update of thrombosis in multiple myeloma.
Topics: Anticoagulants; Antineoplastic Agents; Aspirin; Heparin, Low-Molecular-Weight; Humans; Lenalidomide; Multiple Myeloma; Thalidomide; Thrombosis; Warfarin | 2016 |
4 trial(s) available for thalidomide and warfarin
| Article | Year |
|---|---|
Prospective evaluation of low-dose warfarin for prevention of thalidomide associated venous thromboembolism.
Topics: Aged; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Multiple Myeloma; Thalidomide; Venous Thrombosis; Warfarin | 2006 |
Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin.
Topics: Activated Protein C Resistance; Adult; Aged; Anticoagulants; Case-Control Studies; Dexamethasone; Factor V; Factor VIII; Female; Humans; Male; Middle Aged; Multiple Myeloma; Prothrombin; Risk Factors; Thalidomide; Thrombophilia; Thrombosis; Venous Thromboembolism; Warfarin | 2010 |
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
Topics: Aged; Anticoagulants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Cardiovascular Diseases; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Humans; Italy; Male; Middle Aged; Multiple Myeloma; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Thalidomide; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2011 |
Evaluation of pharmacokinetic and pharmacodynamic interactions when lenalidomide is co-administered with warfarin in a randomized clinical trial setting.
Topics: Adult; Anticoagulants; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Humans; Immunologic Factors; International Normalized Ratio; Lenalidomide; Male; Middle Aged; Prothrombin Time; Thalidomide; Warfarin; Young Adult | 2015 |
25 other study(ies) available for thalidomide and warfarin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The value of case reports in human teratology.
Topics: Abnormalities, Drug-Induced; Animals; Antiemetics; Dicyclomine; Doxylamine; Drug Combinations; Erythromycin; Female; Humans; Infant, Newborn; Isotretinoin; Medical Records; Pregnancy; Publishing; Pyridoxine; Teratogens; Thalidomide; Tretinoin; Warfarin | 1986 |
The susceptibility of the fetus and child to chemical pollutants. Chemicals in human teratogenesis and transplacental carcinogenesis.
Topics: Abnormalities, Drug-Induced; Alkylating Agents; Amphetamine; Androgens; Anticonvulsants; Antithyroid Agents; Carcinogens; Cerebral Palsy; Diethylstilbestrol; Estrogens; Female; Fetus; Folic Acid Antagonists; Gestational Age; Humans; Lead; Maternal-Fetal Exchange; Methylmercury Compounds; Neoplasms; Polychlorinated Biphenyls; Pregnancy; Progesterone; Streptomycin; Tetracycline; Thalidomide; Tooth; Transposition of Great Vessels; Warfarin | 1974 |
[Drugs during pregnancy].
Topics: Antineoplastic Agents; Calcium; Coumarins; Ergot Alkaloids; Female; Hormones; Humans; Iron; Pregnancy; Pregnancy Complications; Quinine; Thalidomide | 1971 |
Teratogenicity: any relationship to carcinogenicity?
Topics: Animals; Carcinogens; Ethanol; Humans; Methotrexate; Mutagens; Teratogens; Testosterone; Thalidomide; Warfarin | 1980 |
Enantioselective supercritical fluid chromatography using ristocetin A chiral stationary phases.
Topics: 2,4-Dichlorophenoxyacetic Acid; Anesthetics, Local; Anti-Bacterial Agents; Bupivacaine; Chromatography, Liquid; Coumarins; Evaluation Studies as Topic; Ketoprofen; Metoprolol; Propranolol; Reagent Kits, Diagnostic; Ristocetin; Stereoisomerism; Thalidomide; Warfarin | 2000 |
Cerebral venous thrombosis in a patient with antiphospholipid syndrome treated with thalidomide.
Topics: Aged; Anticoagulants; Antiphospholipid Syndrome; Humans; Immunosuppressive Agents; International Normalized Ratio; Intracranial Thrombosis; Male; Thalidomide; Warfarin | 2004 |
A simplified synthesis of polymeric nonparticulate stationary phases with macrocyclic antibiotic as chiral selector for capillary electrochromatography.
Topics: Anti-Bacterial Agents; Bupivacaine; Chromatography, Micellar Electrokinetic Capillary; Cross-Linking Reagents; Molecular Structure; Polymers; Stereoisomerism; Tartrates; Thalidomide; Vancomycin; Warfarin | 2004 |
Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antineoplastic Agents; Drug Synergism; Erythropoietin; Female; Humans; Male; Middle Aged; Multiple Myeloma; Recombinant Proteins; Risk; Thalidomide; Thrombosis; Venous Thrombosis; Warfarin | 2004 |
Arterial thrombosis in four patients treated with thalidomide.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Drug Therapy, Combination; Female; Humans; Intracranial Thrombosis; Lymphoma; Male; Middle Aged; Multiple Myeloma; Thalidomide; Thrombosis; Warfarin | 2005 |
Treatment options and considerations for the newly diagnosed myeloma patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Dexamethasone; Enoxaparin; Humans; Male; Middle Aged; Multiple Myeloma; Prognosis; Thalidomide; Venous Thrombosis; Warfarin | 2005 |
Efficacy of prophylactic warfarin for prevention of thalidomide-related deep venous thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticoagulants; Cohort Studies; Female; Hemorrhage; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Thalidomide; Venous Thrombosis; Warfarin | 2006 |
[Picture in clinical hematology no.42].
Topics: Aged; Anticoagulants; Female; Heparin; Humans; Multiple Myeloma; Pulmonary Embolism; Thalidomide; Tomography, X-Ray Computed; Warfarin | 2010 |
Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis.
Topics: Activated Protein C Resistance; Aged; Anticoagulants; Aspirin; Boronic Acids; Bortezomib; Dexamethasone; Humans; Immunologic Factors; International Normalized Ratio; Lenalidomide; Multiple Myeloma; Proteasome Inhibitors; Pyrazines; Risk Factors; Thalidomide; Thrombosis; Venous Thromboembolism; Warfarin | 2011 |
Thromboprophylaxis in multiple myeloma: is the evidence there?
Topics: Antineoplastic Agents; Aspirin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Immunomodulation; Multiple Myeloma; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Adjustment; Secondary Prevention; Thalidomide; Venous Thromboembolism; Warfarin | 2012 |
Deep venous thrombosis and pulmonary embolism secondary to co-administration of thalidomide and oral corticosteroid in a patient with leprosy.
Topics: Adrenal Cortex Hormones; Cyclosporine; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Pulmonary Embolism; Radiography; Thalidomide; Treatment Outcome; Venous Thrombosis; Warfarin | 2012 |
Thromboprophylaxis prescribing and thrombotic event rates in multiple myeloma patients treated with lenalidomide or thalidomide at a specialist cancer hospital.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticoagulants; Aspirin; Cancer Care Facilities; Enoxaparin; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Incidence; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Practice Patterns, Physicians'; Prognosis; Retrospective Studies; Specialization; Thalidomide; Thrombosis; Warfarin | 2013 |
A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of throm
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cohort Studies; Female; Humans; Incidence; Japan; Male; Middle Aged; Multiple Myeloma; Retrospective Studies; Risk Factors; Thalidomide; Venous Thromboembolism; Warfarin | 2013 |
Increased PAC-1 expression among patients with multiple myeloma on concurrent thalidomide and warfarin.
Topics: Aged; Antibodies, Monoclonal; Anticoagulants; Blood Platelets; Female; Gene Expression; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Myeloma; P-Selectin; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Thalidomide; Thrombosis; Warfarin | 2013 |
Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation.
Topics: Abnormalities, Drug-Induced; Angiotensin-Converting Enzyme Inhibitors; Animals; Female; Fetal Diseases; Fetus; Fluconazole; Humans; Isoxazoles; Leflunomide; Mutation; Mycophenolic Acid; Phenotype; Pregnancy; Teratogenesis; Teratogens; Thalidomide; Warfarin | 2017 |
Efficacy and Safety of Danshen Compound Tablets in Preventing Thalidomide-Associated Thromboembolism in Patients with Multiple Myeloma: A Multicenter Retrospective Study.
Topics: Adult; Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Female; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; Multiple Myeloma; Phytotherapy; Plant Preparations; Retrospective Studies; Risk Factors; Salvia miltiorrhiza; Tablets; Thalidomide; Venous Thromboembolism; Warfarin | 2016 |
Species Specificity and Selection of Models for Drug Oxidations Mediated by Polymorphic Human Enzymes.
Topics: Animals; Coumarins; Cytochrome P-450 Enzyme System; Female; Humans; Microsomes, Liver; Oxidation-Reduction; Pregnancy; Rabbits; Rats; Species Specificity; Thalidomide | 2023 |